Catherine Campbell

Catherine Campbell

Company: 4D Molecular Therapeutics

Job title: Vice President - Regulatory Affairs, Quality & Good Practice Compliance Ccampbell@ 4dmt. Com


Regulatory Strategies & Platform Approaches to Accelerate Development of Gene Therapy 12:30 pm

Leveraging a platform approach to streamline gene therapy development Discussing ideal vector choice, transgene payloads, promoters, and strategies to leverage platform vectors to treat multiple disease indications. Pre-IND, nonclinical, CMC, clinical and regulatory strategies and approaches to accelerate developmentRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.